Safety of antiviral medication for the treatment of herpes during pregnancy

Canadian Family Physician

Volumn 57, Issue 4, 2011, Pages 427-428

  Kang, So Hee ^a   Chua Gocheco, Angela ^a   Bozzo, Pina ^a   Einarson, Adrienne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ACICLOVIR TRIPHOSPHATE; FAMCICLOVIR; PENCICLOVIR; VALACICLOVIR;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; BIRTH DEFECT; CASE REPORT; CONGENITAL MALFORMATION; DRUG ABSORPTION; DRUG CHOICE; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STABILITY; FEMALE; FIRST TRIMESTER PREGNANCY; GENITAL HERPES; GYNECOLOGIC INFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; PREGNANT WOMAN; SHORT SURVEY; SINGLE DRUG DOSE; TERATOGENICITY;

2-AMINOPURINE; ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HERPES GENITALIS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SIMPLEXVIRUS; VALINE;

EID: 79954461377     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121(11):847-54.
2. Howard M, Sellors JW, Jang D, Robinson NJ, Fearon M, Kaczorowski J, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003;41(1):84-9. (Pubitemid 36098558)
3. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001;28(7):424-8. (Pubitemid 32613687)
4. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296(8):964-73. (Pubitemid 44285373)
5. Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Chiarini F, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J 2009;6:40.
6. Kropp RY, Wong T, Cormier L, Ringrose A, Burton S, Embree JE, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006;117(6):1955-62. (Pubitemid 46071239)
7. Ormrod D, Scott LJ, Perry CM. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Drugs 2000;59(4):839-63. (Pubitemid 30232326)
8. Simpson D, Lyseng-Williamson KA. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes. Drugs 2006;66(18):2397-416. (Pubitemid 46084812)
9. Denavir cream 1% [package insert]. Parsippany, NJ: Novartis Consumer Health, Inc; 2002.
10. Zovirax cream 5% [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2002.
11. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008;(1):CD004946.
12. GlaxoSmithKline. Acyclovir pregnancy registry and valacyclovir pregnancy registry [interim report]. Research Triangle Park, NC: Glaxo Wellcome; 1997.
13. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010;304(8):859-66.